CrossrefInfokarte
Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19
Journal of Thrombosis and Thrombolysis · 2021-08 · 52 (2) · 497-503
DOI: 10.1007/s11239-021-02457-9 ↗Abstract
Kein Abstract verfügbar.
EUVIMED